| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da14fce0a105f405a943afdb03217c89 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-320725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-22084 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-320758
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0021 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-01 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00 |
| filingDate |
2001-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2825153632e791f84918d42eab74dca4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f92c4b1531179228d25379f3ca4f0ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b6fe70d5744ff225a9e4c4be88ffef9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9190facdb8bc12f405b46c56106ad6c0 |
| publicationDate |
2008-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1251892-A4 |
| titleOfInvention |
SYSTEMS AND METHODS FOR LOADING GERINSELN |
| abstract |
Clot disruption and dissolution are achieved using a catheter (12) having both an agitator (30) and the ability to deliver a thrombolytic agent. The catheter (12) is introduced to a target region with a blood vessel and the agitator (30) manipulated to engage and disrupt a region of clot therein. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator (30) is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved. |
| priorityDate |
2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |